Medical News

RSS

Study: Dietary polyunsaturated fatty acids may reduce coronary heart disease risk

A recent study completed at the University of Eastern Finland shows that dietary polyunsaturated fatty acids may reduce the risk of coronary heart disease. The sources of polyunsaturated fatty acids include fish, vegetable oils, and nuts.

30 Sep 2014

ChromaDex closes $5.0 million growth capital debt financing

ChromaDex Corp., an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today that it closed on a $5.0 million growth capital debt financing from Hercules Technology Growth Capital.

30 Sep 2014

Prenatal maternal stress exposure to Quebec ice storm predicts epigenetic profile of offspring

The number of days an expectant mother was deprived of electricity during Quebec's Ice Storm (1998) predicts the epigenetic profile of her child, a new study finds.

30 Sep 2014

CytRx begins aldoxorubicin Phase 2b clinical trial in patients with extensive-stage SCLC

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced the initiation of a global Phase 2b clinical trial evaluating aldoxorubicin compared to topotecan in subjects with extensive-stage small cell lung cancer (SCLC) who have relapsed or were refractory to prior chemotherapy.

30 Sep 2014

Primco Management announces acquisition of 51% interest in Pops Edibles

Primco Management Inc., a medical marijuana, real estate management and multi-media company today announced that the Company has acquired a 51% interest in Pops Edibles, a San Francisco bay area based medical marijuana boutique that specializes in the formulation and manufacture of both Tetrahydrocannabinol ("THC") and Cannabidiol ("CBD") based 100% organic lollipops designed for both the medical and recreational communities.

30 Sep 2014

Par Pharmaceutical starts shipping generic version of Exforge

Par Pharmaceutical Companies, Inc. today announced that it has begun shipping all four strengths of amlodipine and valsartan tablets, the generic version of Novartis' Exforge. Par received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for amlodipine and valsartan and was granted 180 days of marketing exclusivity.

30 Sep 2014

Researchers uncover molecular interaction between key proteins in cell division

Researchers from Guillermo Montoya's team at the Spanish National Cancer Research Centre (CNIO), in collaboration with Isabelle Vernos' Group from the Centre for Genomic Regulation (CRG), have uncovered the molecular interaction between TACC3 and chTOG, key proteins in forming the internal cellular framework that enables and sustains cell division.

30 Sep 2014

Chef-made meals can increase participation in NSLP, raise vegetable consumption by 16%

Gourmet pizza in school? According to a new Food and Brand Lab pilot study, published in Appetite, chef-made meals can increase participation in the National School Lunch Program (NSLP) by 9% and overall selection and consumption of vegetables by 16%!

30 Sep 2014

ProMedica and Harbor team up to address growing community need for mental health services

Today ProMedica and Harbor announced plans to form a joint operating company (JOC) to address a growing community need for mental health services in northwest Ohio and southeast Michigan.

30 Sep 2014

Pemetrexed/docetaxel with cisplatin achieve similar progression-free survival in NSCLC patients

The first direct comparison of treating non-squamous lung cancer with either pemetrexed or docetaxel in addition to cisplatin has shown that the two combinations achieve similar progression-free survival, although docetaxel was associated with more frequent adverse events.

30 Sep 2014

Brain & Behavior Research Foundation to honor 8 scientists for achievements in psychiatric research

The Brain & Behavior Research Foundation will honor eight scientists with its 2014 Outstanding Achievement Prizes for work delving into psychiatric disorders that affect one in four people. The awards, which celebrate the transformative power of neuroscience and psychiatric research to improve the lives of people with mental illness, will be presented at the Foundation's National Awards Dinner at the Pierre Hotel.

30 Sep 2014

Findings indicate that our bodies are used as perceptual "ruler" to measure the world around us

People tend to perceive their dominant hand as staying relatively the same size even when it's magnified, lending support to the idea that we use our hand as a constant perceptual "ruler" to measure the world around us.

30 Sep 2014

California's drought linked to human-caused climate change, say Stanford scientists

The atmospheric conditions associated with the unprecedented drought currently afflicting California are "very likely" linked to human-caused climate change, Stanford scientists say.

30 Sep 2014

Trastuzumab offers better outcome than lapatinib for HER2-positive breast cancer patients

Analysis of more than 8,000 women who participated in the world's largest study of two treatments for HER2-positive breast cancer reinforces other findings from the clinical trial showing that trastuzumab (Herceptin) should remain the standard of care for this cancer, says a Mayo Clinic researcher.

30 Sep 2014

Patrick F. Sullivan honored with 2014 Lieber Prize for making contributions to schizophrenia research

Patrick F. Sullivan, MD, FRANZCP, M. Hayworth & Family Distinguished Professor of Psychiatry and Professor of Genetics and Psychiatry at the University of North Carolina School of Medicine, is one of two researchers awarded the 2014 Lieber Prize for Outstanding Achievement in Schizophrenia Research.

30 Sep 2014

UCSF gets CDC grant to provide expert guidance to clinicians who prescribe anti-HIV medications

The UCSF Clinician Consultation Center at San Francisco General Hospital and Trauma Center has been funded by the Centers for Disease Control and Prevention to provide a PrEPline, a telephone consultation service that gives expert guidance to healthcare providers across the nation who prescribe antiretroviral medications to HIV uninfected individuals to prevent HIV.

30 Sep 2014

AAN releases new position statement on opioids for chronic non-cancer pain

According to a new position statement from the American Academy of Neurology, the risk of death, overdose, addiction or serious side effects with prescription opioids outweigh the benefits in chronic, non-cancer conditions such as headache, fibromyalgia and chronic low back pain.

30 Sep 2014

TSRI study points way to potential therapies for hereditary spastic paraplegia

Scientists at The Scripps Research Institute have discovered that a gene mutation linked to hereditary spastic paraplegia, a disabling neurological disorder, interferes with the normal breakdown of triglyceride fat molecules in the brain. The TSRI researchers found large droplets of triglycerides within the neurons of mice modeling the disease.

30 Sep 2014

Novel imaging technique could revolutionise diagnosis of neuroblastoma

CANCER RESEARCH UK's Centre for Drug Development, in collaboration with the Rising Tide Foundation, a Swiss-based non-profit organisation which funds innovative cancer trials, today (TUESDAY) announce a new trial at The Royal Marsden and University College London that could revolutionise how children with one of the deadliest forms of cancer are diagnosed.

30 Sep 2014

Yorkshire Cancer Research to invest £5 million to find root causes of cancer problems

YORKSHIRE Cancer Research will invest £5 million in research that will have a direct impact on cancer patients in Yorkshire, it has been announced today.

30 Sep 2014

Medical News

Study: Dietary polyunsaturated fatty acids may reduce coronary heart disease risk

ChromaDex closes $5.0 million growth capital debt financing

Prenatal maternal stress exposure to Quebec ice storm predicts epigenetic profile of offspring

CytRx begins aldoxorubicin Phase 2b clinical trial in patients with extensive-stage SCLC

Primco Management announces acquisition of 51% interest in Pops Edibles

Par Pharmaceutical starts shipping generic version of Exforge

Researchers uncover molecular interaction between key proteins in cell division

Chef-made meals can increase participation in NSLP, raise vegetable consumption by 16%

ProMedica and Harbor team up to address growing community need for mental health services

Pemetrexed/docetaxel with cisplatin achieve similar progression-free survival in NSCLC patients

Brain & Behavior Research Foundation to honor 8 scientists for achievements in psychiatric research

Findings indicate that our bodies are used as perceptual "ruler" to measure the world around us

California's drought linked to human-caused climate change, say Stanford scientists

Trastuzumab offers better outcome than lapatinib for HER2-positive breast cancer patients

Patrick F. Sullivan honored with 2014 Lieber Prize for making contributions to schizophrenia research

UCSF gets CDC grant to provide expert guidance to clinicians who prescribe anti-HIV medications

AAN releases new position statement on opioids for chronic non-cancer pain

TSRI study points way to potential therapies for hereditary spastic paraplegia

Novel imaging technique could revolutionise diagnosis of neuroblastoma

Yorkshire Cancer Research to invest £5 million to find root causes of cancer problems

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Membrane proteins in focus: Turning high-risk targets into routine workflows

Latest News